Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC

Recruiting

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(11 sites)

United States

VA Palo Alto Health Care System, Palo Alto, CA, Palo Alto, California

Jesse Brown VA Medical Center, Chicago, IL, Chicago, Illinois

Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis, Indiana

Robley Rex VA Medical Center, Louisville, KY, Louisville, Kentucky

VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor, Michigan